{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T09:08:18Z","timestamp":1780564098591,"version":"3.54.1"},"reference-count":30,"publisher":"The Company of Biologists","issue":"6","license":[{"start":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T00:00:00Z","timestamp":1780531200000},"content-version":"vor","delay-in-days":1,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"University Hospital of Regensburg"},{"name":"University Regensburg"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,6,15]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:p>Metabolic dysfunction-associated steatotic liver disease (MASLD) and its progressive form, metabolic dysfunction-associated steatohepatitis (MASH), are characterized by lipid accumulation, inflammation, and fibrosis. Existing preclinical models often fail to capture multicellular interactions that shape disease progression. In this study, we established a human multicellular 3D liver spheroid model comprising HepaRG hepatocytes, hepatic stellate cells, liver sinusoidal endothelial cells, and Kupffer cells. Spheroids were analyzed for lipid accumulation, cytokine secretion, hepatocellular injury, and extracellular matrix remodeling using immunofluorescence, qPCR, ELISA, and LDH release assays. The model exhibited multicellular spatial organization resembling the native liver microarchitecture. Lipid accumulation was most pronounced under MASLD conditions, whereas progression to MASH was associated with stronger inflammatory and fibrosis-related changes. TNF-\u03b1 showed the clearest Kupffer cell-associated increase, whereas IL-6 changes were less consistent and likely reflected the broader inflammatory response of a multicellular system. LDH release increased with disease severity and was most pronounced in MASH without evidence of a robust Kupffer cell-specific effect. Fibrotic remodeling was reflected by increased expression of fibronectin, collagen III, and procollagen I. Together, these findings establish a human multicellular in vitro platform that recapitulates the key disease-relevant features of MASLD\/MASH under controlled conditions.<\/jats:p>","DOI":"10.1242\/bio.062552","type":"journal-article","created":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T08:31:36Z","timestamp":1779093096000},"source":"Crossref","is-referenced-by-count":0,"title":["Glimpse into the role of Kupffer cells in a spheroid model of metabolic dysfunction-associated steatohepatitis (MASH)"],"prefix":"10.1242","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0009-0006-5094-0043","authenticated-orcid":false,"given":"Niklas","family":"Bogovic","sequence":"first","affiliation":[{"name":"University Hospital Regensburg Department of Surgery , , 93053 Regensburg ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Drie\u00dflein","sequence":"additional","affiliation":[{"name":"University Hospital Regensburg Department of Surgery , , 93053 Regensburg ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"Keller","sequence":"additional","affiliation":[{"name":"University Hospital Regensburg Department of Surgery , , 93053 Regensburg ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans J.","family":"Schlitt","sequence":"additional","affiliation":[{"name":"University Hospital Regensburg Department of Surgery , , 93053 Regensburg ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3661-6168","authenticated-orcid":false,"given":"Edward K.","family":"Geissler","sequence":"additional","affiliation":[{"name":"University Hospital Regensburg Department of Surgery , , 93053 Regensburg ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lydia","family":"Schneider","sequence":"additional","affiliation":[{"name":"University Hospital Regensburg Department of Surgery , , 93053 Regensburg ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philipp","family":"Kreiner","sequence":"additional","affiliation":[{"name":"University Hospital Regensburg Department of Surgery , , 93053 Regensburg ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henrik","family":"Junger","sequence":"additional","affiliation":[{"name":"University Hospital Regensburg Department of Surgery , , 93053 Regensburg ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elke","family":"Eggenhofer","sequence":"additional","affiliation":[{"name":"University Hospital Regensburg Department of Surgery , , 93053 Regensburg ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"237","published-online":{"date-parts":[[2026,6,3]]},"reference":[{"key":"2026060404434917800_BIO062552C1","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1124\/dmd.105.006759","article-title":"Expression of cytochromes P450, conjugating enzymes and nuclear receptors in human hepatoma HepaRG cells","volume":"34","author":"Aninat","year":"2006","journal-title":"Drug. Metab. Dispos."},{"key":"2026060404434917800_BIO062552C2","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1146\/annurev-pathol-020117-043617","article-title":"Recent insights into the pathogenesis of nonalcoholic fatty liver disease","volume":"13","author":"Arab","year":"2018","journal-title":"Annu. Rev. Pathol. Mech. Dis."},{"key":"2026060404434917800_BIO062552C3","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1007\/s00204-020-02682-w","article-title":"Functionality of primary hepatic non-parenchymal cells in a 3D spheroid model and contribution to acetaminophen hepatotoxicity","volume":"94","author":"Bell","year":"2020","journal-title":"Arch. Toxicol."},{"key":"2026060404434917800_BIO062552C4","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/j.phrs.2018.06.029","article-title":"Human-based systems: Mechanistic NASH modelling just around the corner?","volume":"134","author":"Boeckmans","year":"2018","journal-title":"Pharmacol. Res."},{"key":"2026060404434917800_BIO062552C5","doi-asserted-by":"publisher","first-page":"727","DOI":"10.3748\/wjg.v18.i8.727","article-title":"Role of cytokines and chemokines in non-alcoholic fatty liver disease","volume":"18","author":"Braunersreuther","year":"2012","journal-title":"World J. Gastroenterol."},{"key":"2026060404434917800_BIO062552C6","doi-asserted-by":"publisher","first-page":"105728","DOI":"10.1016\/j.tiv.2023.105728","article-title":"3D multi-cell-type liver organoids: A new model of non-alcoholic fatty liver disease for drug safety assessments","volume":"94","author":"Bronsard","year":"2024","journal-title":"Toxicol. In Vitro"},{"key":"2026060404434917800_BIO062552C7","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.1016\/j.metabol.2015.12.012","article-title":"The multiple-hit pathogenesis of non-alcoholic fatty liver disease (NAFLD)","volume":"65","author":"Buzzetti","year":"2016","journal-title":"Metabolism"},{"key":"2026060404434917800_BIO062552C8","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1002\/hep.29367","article-title":"The diagnosis and management of nonalcoholic fatty liver disease: practice guidance from the American association for the study of liver diseases","volume":"67","author":"Chalasani","year":"2018","journal-title":"Hepatology"},{"key":"2026060404434917800_BIO062552C9","doi-asserted-by":"publisher","first-page":"2007425","DOI":"10.1002\/smll.202007425","article-title":"Bioengineered multicellular liver microtissues for modeling advanced hepatic fibrosis driven through non-alcoholic fatty liver disease","volume":"17","author":"Cho","year":"2021","journal-title":"Small"},{"key":"2026060404434917800_BIO062552C10","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1080\/17460441.2018.1410135","article-title":"Non-alcoholic fatty liver disease (NAFLD) models in drug discovery","volume":"13","author":"Cole","year":"2018","journal-title":"Expert Opin. Drug Discov."},{"key":"2026060404434917800_BIO062552C11","doi-asserted-by":"publisher","first-page":"984578","DOI":"10.1155\/2015\/984578","article-title":"How inflammation impinges on NAFLD: a role for Kupffer cells","volume":"2015","author":"Duarte","year":"2015","journal-title":"BioMed Res. Int."},{"key":"2026060404434917800_BIO062552C12","doi-asserted-by":"publisher","first-page":"1557","DOI":"10.1002\/hep.29085","article-title":"Increased risk of mortality by fibrosis stage in nonalcoholic fatty liver disease: Systematic review and meta-analysis","volume":"65","author":"Dulai","year":"2017","journal-title":"Hepatology"},{"key":"2026060404434917800_BIO062552C13","doi-asserted-by":"publisher","first-page":"2241","DOI":"10.1002\/hep.30333","article-title":"Mouse models of nonalcoholic steatohepatitis: toward optimization of their relevance to human nonalcoholic steatohepatitis","volume":"69","author":"Farrell","year":"2019","journal-title":"Hepatology"},{"key":"2026060404434917800_BIO062552C14","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1152\/physrev.00013.2007","article-title":"Hepatic stellate cells: protean, multifunctional, and enigmatic cells of the liver","volume":"88","author":"Friedman","year":"2008","journal-title":"Physiol. Rev."},{"key":"2026060404434917800_BIO062552C15","doi-asserted-by":"publisher","first-page":"1707","DOI":"10.1016\/j.drudis.2017.06.007","article-title":"Mouse models of nonalcoholic steatohepatitis in preclinical drug development","volume":"22","author":"Hansen","year":"2017","journal-title":"Drug Discov. Today"},{"key":"2026060404434917800_BIO062552C16","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1002\/cpmo.3","article-title":"An overview of mouse models of nonalcoholic steatohepatitis: from past to present","volume":"6","author":"Jacobs","year":"2016","journal-title":"Curr. Protoc. Mouse Biol."},{"key":"2026060404434917800_BIO062552C17","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1016\/j.bbadis.2018.06.023","article-title":"Animal models of NAFLD from a hepatologist's point of view","volume":"1865","author":"Jahn","year":"2019","journal-title":"Biochim. Biophys. Acta BBA Mol. Basis Dis."},{"key":"2026060404434917800_BIO062552C18","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1038\/s41575-018-0082-x","article-title":"The role of macrophages in nonalcoholic fatty liver disease and nonalcoholic steatohepatitis","volume":"16","author":"Kazankov","year":"2019","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"2026060404434917800_BIO062552C19","doi-asserted-by":"publisher","first-page":"14297","DOI":"10.1038\/s41598-018-32722-6","article-title":"Human hepatic 3D spheroids as a model for steatosis and insulin resistance","volume":"8","author":"Kozyra","year":"2018","journal-title":"Sci. Rep."},{"key":"2026060404434917800_BIO062552C20","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1038\/nri.2017.11","article-title":"Liver macrophages in tissue homeostasis and disease","volume":"17","author":"Krenkel","year":"2017","journal-title":"Nat. Rev. Immunol."},{"key":"2026060404434917800_BIO062552C21","doi-asserted-by":"publisher","first-page":"2959","DOI":"10.3390\/ijms26072959","article-title":"Metabolic-dysfunction-associated steatotic liver disease: molecular mechanisms, clinical implications, and emerging therapeutic strategies","volume":"26","author":"Mej\u00eda-Guzm\u00e1n","year":"2025","journal-title":"Int. J. Mol. Sci."},{"key":"2026060404434917800_BIO062552C22","first-page":"1531","article-title":"Development and validation of an in vitro 3D model of NASH with severe fibrotic phenotype","volume":"11","author":"Mukherjee","year":"2019","journal-title":"Am. J. Transl. Res."},{"key":"2026060404434917800_BIO062552C23","doi-asserted-by":"publisher","first-page":"e32785","DOI":"10.1371\/journal.pone.0032785","article-title":"Sinusoidal endothelial dysfunction precedes inflammation and fibrosis in a model of NAFLD","volume":"7","author":"Pasar\u00edn","year":"2012","journal-title":"PLoS ONE"},{"key":"2026060404434917800_BIO062552C24","doi-asserted-by":"publisher","first-page":"1629","DOI":"10.3390\/ijms20071629","article-title":"Human multilineage 3D spheroids as a model of liver steatosis and fibrosis","volume":"20","author":"Pingitore","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"2026060404434917800_BIO062552C25","doi-asserted-by":"publisher","first-page":"36750","DOI":"10.1038\/srep36750","article-title":"Activated hepatic stellate cells play pivotal roles in hepatocellular carcinoma cell chemoresistance and migration in multicellular tumor spheroids","volume":"6","author":"Song","year":"2016","journal-title":"Sci. Rep."},{"key":"2026060404434917800_BIO062552C26","doi-asserted-by":"publisher","first-page":"22765","DOI":"10.1038\/s41598-021-01951-7","article-title":"A 3D primary human cell-based in vitro model of non-alcoholic steatohepatitis for efficacy testing of clinical drug candidates","volume":"11","author":"Str\u00f6bel","year":"2021","journal-title":"Sci. Rep."},{"key":"2026060404434917800_BIO062552C27","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1038\/nrgastro.2017.38","article-title":"Mechanisms of hepatic stellate cell activation","volume":"14","author":"Tsuchida","year":"2017","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"2026060404434917800_BIO062552C28","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1053\/j.gastro.2018.04.034","article-title":"Fibrosis severity as a determinant of cause-specific mortality in patients with advanced nonalcoholic fatty liver disease: a multi-national cohort study","volume":"155","author":"Vilar-Gomez","year":"2018","journal-title":"Gastroenterology"},{"key":"2026060404434917800_BIO062552C29","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/nrgastro.2017.109","article-title":"Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention","volume":"15","author":"Younossi","year":"2018","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"2026060404434917800_BIO062552C30","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1186\/s12876-025-04057-w","article-title":"Association of serum lactate dehydrogenase levels with non-alcoholic fatty liver disease and advanced hepatic fibrosis in the United States: a cross-sectional study using NHANES data from 2007 to 2018","volume":"25","author":"Zhang","year":"2025","journal-title":"BMC Gastroenterol."}],"container-title":["Biology Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.biologists.com\/bio\/article-pdf\/doi\/10.1242\/bio.062552\/3699798\/bio062552.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/journals.biologists.com\/bio\/article-pdf\/doi\/10.1242\/bio.062552\/3702018\/bio062552.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/journals.biologists.com\/bio\/article-pdf\/doi\/10.1242\/bio.062552\/3702018\/bio062552.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T08:43:52Z","timestamp":1780562632000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.biologists.com\/bio\/article\/15\/6\/bio062552\/371875\/Glimpse-into-the-role-of-Kupffer-cells-in-a"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,3]]},"references-count":30,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,6,15]]}},"URL":"https:\/\/doi.org\/10.1242\/bio.062552","relation":{},"ISSN":["2046-6390"],"issn-type":[{"value":"2046-6390","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,3]]},"article-number":"bio062552"}}